Findings from Donald and Barbara Zucker School of Medicine at Hofstra in the Area of Managed Care Described [Prescribing Trends for Vaginal Estrogen: What role do Urogynecology & Reconstructive Pelvic Surgery (URPS) urologists play?]: Managed Care

2025 OCT 24 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Researchers detail new data in Managed Care. According to news reporting originating from Hempstead, New York, by NewsRx correspondents, research stated, “To evaluate the impact of URPS board certification on prescribing trends of vaginal estrogen (VE) by urologists participating in Medicare Part D. The Medicare Part D Prescriber dataset was queried from 2016 to 2018 to identify urologists who made VE claims.”

Our news editors obtained a quote from the research from the Donald and Barbara Zucker School of Medicine at Hofstra, “Board certification status was obtained from the American Board of Urology website. Urologist gender was obtained from the National Plan & Provider Enumeration System NPI registry. Parametric statistics were used to analyze claims and expenditure trends. From 2016 to 2018, 2,367 urologists were identified with VE claims, including 272 board-certified in URPS. URPS urologists had more claims per prescriber than non-URPS urologists for all years (2016: 42.9 vs 26.7, p<0.01; 2017:42 vs 27.4, p<0.01; 2018:30.1 vs 23.9, p<0.01). Female urologists had more claims per prescriber than male urologists in 2016 (36.9 vs. 26.5, p<0.01) and 2017 (37.9 vs. 26.8, p<0.01). On multivariate analysis, URPS fellowship (b=8.6, 95% CI 6.3-10.8, p<0.01) and female gender of prescriber (b=4.9, 95% CI 3.1-6.7, p<0.01) were significant predictors for making more VE claims. Within URPS urologists, there was no significant difference in average VE claims between male and female prescribers. Both URPS and female urologists made more VE claims per prescriber than non-URPS urologists.”

According to the news editors, the research concluded: “These findings may reflect referral patterns or reveal discrepancies in how urologists treat genitourinary syndrome of menopause.”

This research has been peer-reviewed.

For more information on this research see: Prescribing Trends for Vaginal Estrogen: What role do Urogynecology & Reconstructive Pelvic Surgery (URPS) urologists play? Urology, 2025. Urology can be contacted at: Elsevier Science Inc, Ste 800, 230 Park Ave, New York, NY 10169, USA. (Elsevier - www.elsevier.com; Urology - http://www.journals.elsevier.com/urology/)

The news editors report that additional information may be obtained by contacting Derek Tran, Donald and Barbara Zucker School of Medicine at Hofstra, Northwell, Hempstead, NY. Additional authors for this research include Jared Faith, Robert Chang, Alexandra L. Tabakin and Wai Lee.

Publisher contact information for the journal Urology is: Elsevier Science Inc, Ste 800, 230 Park Ave, New York, NY 10169, USA.

(Our reports deliver fact-based news of research and discoveries from around the world.)